Correspondence 0001213900-22-070564 from INTENSITY THERAPEUTICS, INC. (INTS)
INTENSITY THERAPEUTICS, INC.
Date: Nov. 9, 2022 · CIK: 0001567264 · Accession: 0001213900-22-070564
AI Filing Summary & Sentiment
File numbers found in text: 333-260565
Letter
Re: Intensity Therapeutics, Inc.
November 9, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-260565
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on November 3, 2022, in which we, as representative of the several underwriters of Intensity Therapeutics, Inc.’s proposed public offering, joined Intensity Therapeutics, Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for November 7, 2022, at 5:30 p.m. Eastern Time. Intensity Therapeutics, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
ROTH CAPITAL PARTNERS,
LLC
Show Raw Text
CORRESP
1
filename1.htm
November 9, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Intensity Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-260565
Ladies and Gentlemen:
Reference is made to our letter,
filed as correspondence via EDGAR on November 3, 2022, in which we, as representative of the several underwriters of Intensity Therapeutics,
Inc.’s proposed public offering, joined Intensity Therapeutics, Inc.’s request for acceleration of the effective date of the
above-referenced Registration Statement for November 7, 2022, at 5:30 p.m. Eastern Time. Intensity Therapeutics, Inc. is no longer requesting
that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the
effective date.
Very truly yours,
ROTH CAPITAL PARTNERS,
LLC
As representative of the
several Underwriters
ROTH CAPITAL PARTNERS, LLC
By:
/s/ Aaron M. Gurewitz
Name:
Aaron M. Gurewitz
Title:
Head of Equity Capital Markets